Back to search
brca1 Mutation Carrier
Clinical trial pipeline · Data from ClinicalTrials.gov
See which brca1 Mutation Carrier trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which brca1 Mutation Carrier trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to learn how people with BRCA1/2 mutations respond to genetic risk modifier testing. The researchers will learn more about how peop…
The goal of this multi-center observational study is to learn about the effectiveness and safety of different prophylactic (preventive) surgical options in wome…
This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovaria…
Subjects who carry mutations in breast cancer susceptibility genes 1 and 2 (BRCA1 and BRCA2 genes) are at higher risk of developing cancers. Despite the cumulat…
Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be res…
The purpose of this study is to assess an intervention that incorporates engagement strategies with a medical team navigator, an educational video and accessibl…
This phase Ib/II trial studies the side effects and best dose of olaparib and vistusertib (AZD2014) or olaparib and capivasertib (AZD5363) when given together i…
This randomized phase III trial studies metformin hydrochloride to see how well it works compared to placebo in preventing breast cancer in patients with atypic…